RNWEX
Price
$105.05
Change
-$1.94 (-1.81%)
Updated
Jul 2 closing price
Net Assets
90.88B
SEKAX
Price
$29.01
Change
-$0.55 (-1.86%)
Updated
Jul 2 closing price
Net Assets
78.66M
Interact to see
Advertisement

RNWEX vs SEKAX

RNWEX vs SEKAX Comparison Chart in %
View a ticker or compare two or three
VS
RNWEX vs. SEKAX commentary
Jul 07, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RNWEX is a Buy and SEKAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RNWEX has more cash in the bank: 90.9B vs. SEKAX (78.7M). SEKAX pays higher dividends than RNWEX: SEKAX (2.08) vs RNWEX (0.97). RNWEX was incepted earlier than SEKAX: RNWEX (24 years) vs SEKAX (25 years). SEKAX (1.72) is less costly to investors than RNWEX (0.92). SEKAX is a more actively managed with annual turnover of: 94.00 vs. RNWEX (46.00). RNWEX has a lower initial minimum investment than SEKAX: RNWEX (250) vs SEKAX (1000). SEKAX annual gain was more profitable for investors over the last year : 46.35 vs. RNWEX (20.11). SEKAX return over 5 years is better than : 27.13 vs. RNWEX (13.51).
RNWEXSEKAXRNWEX / SEKAX
Total Expense Ratio0.921.1580%
Annual Report Gross Expense Ratio0.921.7253%
Fund Existence24 years25 years-
Gain YTD13.51828.07948%
Front LoadN/A6%-
Min. Initial Investment250100025%
Min. Initial Investment IRAN/AN/A-
Net Assets90.9B78.7M115,502%
Annual Yield % from dividends0.972.0846%
Returns for 1 year20.1146.3543%
Returns for 3 years46.9981.2958%
Returns for 5 years13.5127.1350%
Returns for 10 years113.76130.7087%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HLHIX31.170.86
+2.84%
Virtus KAR Health Sciences Inst
CCCNX7.800.06
+0.78%
Center Coast Brookfield Midstream Foc I
FLPKX46.280.27
+0.59%
Fidelity Low-Priced Stock K
CDOFX53.78-0.27
-0.50%
Crawford Small Cap Dividend
JSGCX26.72-0.51
-1.87%
JHancock U.S. Growth C